NCT00043225View on ClinicalTrials.gov

The Role of Bacteria and Genetic Variations in Cystic Fibrosis

CompletedOBSERVATIONAL
Enrollment

76

Participants

Timeline

Start Date

June 20, 2001

Primary Completion Date

July 10, 2018

Study Completion Date

July 10, 2018

Conditions
Psuedomas InfectionCystic Fibrosis
Trial Locations (4)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

53792

University of Wisconsin, Madison

98195

University of Washington, Seattle

Unknown

Medical College of Wisconsin, Milwaukee

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00043225 - The Role of Bacteria and Genetic Variations in Cystic Fibrosis | Biotech Hunter | Biotech Hunter